Outset Medical has raised $125 million to accelerate the U.S. commercialization of its all-in-one hemodialysis machine. About the size of a small cart on wheels, the Tablo system includes onboard ...
After raising $125 million for its commercialization efforts earlier this year, portable dialysis machine manufacturer Outset Medical is now going public with a $241.7 million Nasdaq IPO. Trading ...
UK-based Quanta Fluid Solutions Ltd said it has successfully treated the first patients with SC+, its portable, cartridge-based hemodialysis system. The treatments were part of a pilot study designed ...
Patients on kidney dialysis now have another option -- a portable machine than can go almost anywhere. Joyce and Ken Eiler had to give up on traveling to dog shows with their prize-winning Samoyeds ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Medical device developer Diality Inc. has closed $12.5 ...
Harvey Wells is a man taking to the road. A modern day Charles Kuralt, Wells is a man on a mission with a message. ìIím here to spread the word and raise public awareness by traveling cross-country ...
PALO ALTO, Calif.--(BUSINESS WIRE)--HP (NYSE:HPQ) and Home Dialysis Plus, Ltd. (HD+), a developer of devices and products for kidney dialysis, today announced a licensing agreement to enable dialysis ...
Soana Fassisila, left, helps her husband Saia, pastor of the United Methodist Church in San Mateo, Calif., hook up his portable dialysis machine in their home. A small but growing shift to home ...
SEATTLE — A Seattle researcher and his team could be among the first scientists to develop a portable, artificial kidney that has the potential to help millions of patients undergoing dialysis for ...
INDIANAPOLIS – A suitcase-sized machine tested at the Indiana University School of Medicine is making life easier for some patients undergoing rigorous dialysis for kidney failure. A year ago, ...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today announced U.S. Food and Drug Administration (FDA) clearance of its next-generation ...